Cargando…

The Human Mixed Lineage Leukemia 5 (MLL5), a Sequentially and Structurally Divergent SET Domain-Containing Protein with No Intrinsic Catalytic Activity

Mixed Lineage Leukemia 5 (MLL5) plays a key role in hematopoiesis, spermatogenesis and cell cycle progression. Chromatin binding is ensured by its plant homeodomain (PHD) through a direct interaction with the N-terminus of histone H3 (H3). In addition, MLL5 contains a Su(var)3-9, Enhancer of zeste,...

Descripción completa

Detalles Bibliográficos
Autores principales: Mas-y-Mas, Sarah, Barbon, Marta, Teyssier, Catherine, Déméné, Hélène, Carvalho, João E., Bird, Louise E., Lebedev, Andrey, Fattori, Juliana, Schubert, Michael, Dumas, Christian, Bourguet, William, le Maire, Albane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094779/
https://www.ncbi.nlm.nih.gov/pubmed/27812132
http://dx.doi.org/10.1371/journal.pone.0165139
_version_ 1782465172899627008
author Mas-y-Mas, Sarah
Barbon, Marta
Teyssier, Catherine
Déméné, Hélène
Carvalho, João E.
Bird, Louise E.
Lebedev, Andrey
Fattori, Juliana
Schubert, Michael
Dumas, Christian
Bourguet, William
le Maire, Albane
author_facet Mas-y-Mas, Sarah
Barbon, Marta
Teyssier, Catherine
Déméné, Hélène
Carvalho, João E.
Bird, Louise E.
Lebedev, Andrey
Fattori, Juliana
Schubert, Michael
Dumas, Christian
Bourguet, William
le Maire, Albane
author_sort Mas-y-Mas, Sarah
collection PubMed
description Mixed Lineage Leukemia 5 (MLL5) plays a key role in hematopoiesis, spermatogenesis and cell cycle progression. Chromatin binding is ensured by its plant homeodomain (PHD) through a direct interaction with the N-terminus of histone H3 (H3). In addition, MLL5 contains a Su(var)3-9, Enhancer of zeste, Trithorax (SET) domain, a protein module that usually displays histone lysine methyltransferase activity. We report here the crystal structure of the unliganded SET domain of human MLL5 at 2.1 Å resolution. Although it shows most of the canonical features of other SET domains, both the lack of key residues and the presence in the SET-I subdomain of an unusually large loop preclude the interaction of MLL5 SET with its cofactor and substrate. Accordingly, we show that MLL5 is devoid of any in vitro methyltransferase activity on full-length histones and histone H3 peptides. Hence, the three dimensional structure of MLL5 SET domain unveils the structural basis for its lack of methyltransferase activity and suggests a new regulatory mechanism.
format Online
Article
Text
id pubmed-5094779
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-50947792016-11-18 The Human Mixed Lineage Leukemia 5 (MLL5), a Sequentially and Structurally Divergent SET Domain-Containing Protein with No Intrinsic Catalytic Activity Mas-y-Mas, Sarah Barbon, Marta Teyssier, Catherine Déméné, Hélène Carvalho, João E. Bird, Louise E. Lebedev, Andrey Fattori, Juliana Schubert, Michael Dumas, Christian Bourguet, William le Maire, Albane PLoS One Research Article Mixed Lineage Leukemia 5 (MLL5) plays a key role in hematopoiesis, spermatogenesis and cell cycle progression. Chromatin binding is ensured by its plant homeodomain (PHD) through a direct interaction with the N-terminus of histone H3 (H3). In addition, MLL5 contains a Su(var)3-9, Enhancer of zeste, Trithorax (SET) domain, a protein module that usually displays histone lysine methyltransferase activity. We report here the crystal structure of the unliganded SET domain of human MLL5 at 2.1 Å resolution. Although it shows most of the canonical features of other SET domains, both the lack of key residues and the presence in the SET-I subdomain of an unusually large loop preclude the interaction of MLL5 SET with its cofactor and substrate. Accordingly, we show that MLL5 is devoid of any in vitro methyltransferase activity on full-length histones and histone H3 peptides. Hence, the three dimensional structure of MLL5 SET domain unveils the structural basis for its lack of methyltransferase activity and suggests a new regulatory mechanism. Public Library of Science 2016-11-03 /pmc/articles/PMC5094779/ /pubmed/27812132 http://dx.doi.org/10.1371/journal.pone.0165139 Text en © 2016 Mas-y-Mas et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Mas-y-Mas, Sarah
Barbon, Marta
Teyssier, Catherine
Déméné, Hélène
Carvalho, João E.
Bird, Louise E.
Lebedev, Andrey
Fattori, Juliana
Schubert, Michael
Dumas, Christian
Bourguet, William
le Maire, Albane
The Human Mixed Lineage Leukemia 5 (MLL5), a Sequentially and Structurally Divergent SET Domain-Containing Protein with No Intrinsic Catalytic Activity
title The Human Mixed Lineage Leukemia 5 (MLL5), a Sequentially and Structurally Divergent SET Domain-Containing Protein with No Intrinsic Catalytic Activity
title_full The Human Mixed Lineage Leukemia 5 (MLL5), a Sequentially and Structurally Divergent SET Domain-Containing Protein with No Intrinsic Catalytic Activity
title_fullStr The Human Mixed Lineage Leukemia 5 (MLL5), a Sequentially and Structurally Divergent SET Domain-Containing Protein with No Intrinsic Catalytic Activity
title_full_unstemmed The Human Mixed Lineage Leukemia 5 (MLL5), a Sequentially and Structurally Divergent SET Domain-Containing Protein with No Intrinsic Catalytic Activity
title_short The Human Mixed Lineage Leukemia 5 (MLL5), a Sequentially and Structurally Divergent SET Domain-Containing Protein with No Intrinsic Catalytic Activity
title_sort human mixed lineage leukemia 5 (mll5), a sequentially and structurally divergent set domain-containing protein with no intrinsic catalytic activity
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094779/
https://www.ncbi.nlm.nih.gov/pubmed/27812132
http://dx.doi.org/10.1371/journal.pone.0165139
work_keys_str_mv AT masymassarah thehumanmixedlineageleukemia5mll5asequentiallyandstructurallydivergentsetdomaincontainingproteinwithnointrinsiccatalyticactivity
AT barbonmarta thehumanmixedlineageleukemia5mll5asequentiallyandstructurallydivergentsetdomaincontainingproteinwithnointrinsiccatalyticactivity
AT teyssiercatherine thehumanmixedlineageleukemia5mll5asequentiallyandstructurallydivergentsetdomaincontainingproteinwithnointrinsiccatalyticactivity
AT demenehelene thehumanmixedlineageleukemia5mll5asequentiallyandstructurallydivergentsetdomaincontainingproteinwithnointrinsiccatalyticactivity
AT carvalhojoaoe thehumanmixedlineageleukemia5mll5asequentiallyandstructurallydivergentsetdomaincontainingproteinwithnointrinsiccatalyticactivity
AT birdlouisee thehumanmixedlineageleukemia5mll5asequentiallyandstructurallydivergentsetdomaincontainingproteinwithnointrinsiccatalyticactivity
AT lebedevandrey thehumanmixedlineageleukemia5mll5asequentiallyandstructurallydivergentsetdomaincontainingproteinwithnointrinsiccatalyticactivity
AT fattorijuliana thehumanmixedlineageleukemia5mll5asequentiallyandstructurallydivergentsetdomaincontainingproteinwithnointrinsiccatalyticactivity
AT schubertmichael thehumanmixedlineageleukemia5mll5asequentiallyandstructurallydivergentsetdomaincontainingproteinwithnointrinsiccatalyticactivity
AT dumaschristian thehumanmixedlineageleukemia5mll5asequentiallyandstructurallydivergentsetdomaincontainingproteinwithnointrinsiccatalyticactivity
AT bourguetwilliam thehumanmixedlineageleukemia5mll5asequentiallyandstructurallydivergentsetdomaincontainingproteinwithnointrinsiccatalyticactivity
AT lemairealbane thehumanmixedlineageleukemia5mll5asequentiallyandstructurallydivergentsetdomaincontainingproteinwithnointrinsiccatalyticactivity
AT masymassarah humanmixedlineageleukemia5mll5asequentiallyandstructurallydivergentsetdomaincontainingproteinwithnointrinsiccatalyticactivity
AT barbonmarta humanmixedlineageleukemia5mll5asequentiallyandstructurallydivergentsetdomaincontainingproteinwithnointrinsiccatalyticactivity
AT teyssiercatherine humanmixedlineageleukemia5mll5asequentiallyandstructurallydivergentsetdomaincontainingproteinwithnointrinsiccatalyticactivity
AT demenehelene humanmixedlineageleukemia5mll5asequentiallyandstructurallydivergentsetdomaincontainingproteinwithnointrinsiccatalyticactivity
AT carvalhojoaoe humanmixedlineageleukemia5mll5asequentiallyandstructurallydivergentsetdomaincontainingproteinwithnointrinsiccatalyticactivity
AT birdlouisee humanmixedlineageleukemia5mll5asequentiallyandstructurallydivergentsetdomaincontainingproteinwithnointrinsiccatalyticactivity
AT lebedevandrey humanmixedlineageleukemia5mll5asequentiallyandstructurallydivergentsetdomaincontainingproteinwithnointrinsiccatalyticactivity
AT fattorijuliana humanmixedlineageleukemia5mll5asequentiallyandstructurallydivergentsetdomaincontainingproteinwithnointrinsiccatalyticactivity
AT schubertmichael humanmixedlineageleukemia5mll5asequentiallyandstructurallydivergentsetdomaincontainingproteinwithnointrinsiccatalyticactivity
AT dumaschristian humanmixedlineageleukemia5mll5asequentiallyandstructurallydivergentsetdomaincontainingproteinwithnointrinsiccatalyticactivity
AT bourguetwilliam humanmixedlineageleukemia5mll5asequentiallyandstructurallydivergentsetdomaincontainingproteinwithnointrinsiccatalyticactivity
AT lemairealbane humanmixedlineageleukemia5mll5asequentiallyandstructurallydivergentsetdomaincontainingproteinwithnointrinsiccatalyticactivity